Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
Aurobindo’s generic equivalent of anti-epileptic drug Dilantin has been approved by the Food and Drug Administration.
Aurobindo Pharma has submitted an abbreviated new drug application for dolutegravir 50 mg to the Food and Drug Administration for the treatment of HIV.
Aurobindo Pharmacy on Monday announced that it has received the first abbreviated new drug approval from the Food and Drug Administration for cefixime for oral suspension
Aurobindo Pharma on Tuesday announced that the company has received final approval from the U.S. Food & Drug Administration to manufacture and market Valsartan Tablets.
Aurobindo Pharma Limited last week announced the completion of its acquisition of supplement maker Natrol through its wholly owned subsidiary Aurobindo Pharma USA for $132.5 million.
Aurobindo Pharma on May 15 gained approval to produce a generic version of olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths.
Actavis Pharma recently announced that it intends to enter into an agreement for Aurobindo Pharma to acquire Actavis' generics commercial operations in seven markets in Western Europe.
The Food and Drug Administration has approved the first generic versions of a drug used to treat depression and other conditions, the agency said.
The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.
The Food and Drug Administration has given preliminary approval to a drug made by Aurobindo Pharma for treating HIV infection, the drug maker said.
The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.